TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $919,119 | +79.7% | 59,413 | +82.4% | 0.00% | +100.0% |
| Q2 2023 | $511,580 | -1.2% | 32,564 | +3.6% | 0.00% | 0.0% |
| Q1 2023 | $517,884 | -9.1% | 31,425 | -14.0% | 0.00% | -33.3% |
| Q4 2022 | $569,884 | +175.3% | 36,531 | +128.9% | 0.00% | +200.0% |
| Q3 2022 | $207,000 | +19.0% | 15,958 | +28.6% | 0.00% | 0.0% |
| Q2 2022 | $174,000 | +43.8% | 12,405 | +47.1% | 0.00% | 0.0% |
| Q1 2022 | $121,000 | -43.2% | 8,434 | -45.9% | 0.00% | 0.0% |
| Q4 2021 | $213,000 | +69.0% | 15,601 | +102.1% | 0.00% | 0.0% |
| Q3 2021 | $126,000 | -14.9% | 7,720 | -12.3% | 0.00% | 0.0% |
| Q2 2021 | $148,000 | 0.0% | 8,804 | +8.6% | 0.00% | -50.0% |
| Q1 2021 | $148,000 | +33.3% | 8,107 | +32.4% | 0.00% | +100.0% |
| Q4 2020 | $111,000 | +50.0% | 6,122 | +45.6% | 0.00% | 0.0% |
| Q3 2020 | $74,000 | +37.0% | 4,204 | +37.7% | 0.00% | 0.0% |
| Q2 2020 | $54,000 | – | 3,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |